Literature DB >> 1099009

Lymphokines in sensitized rats. I. Migration inhibitory factor(s) from specifically stimulated thymocytes in vitro.

W W Bakker, J J Engelhart, I Mulder, P J Hoedemaeker.   

Abstract

Cell-mediated immune responses were studied in Wistar rats by migration inhibition factor (MIF) assays in vitro of lymphoid cells derived from thymus, spleen and peripheral blood and peritoneal exudates and by delayed cutaneous hypersensitivity reactions in vivo. Using PPD and purified diphtheria toxoid as soluble test antigens it appeared that significant migration inhibition was observed only when sensitized thymus and peritoneal exudate cells were used in the direct capillary migration system. Indirect MIF assays, using both capillary and agarose techniques, showed that migration inhibitory activity was found in thymus culture supernatants as well as in spleen culture supernatants of sensitized animals. The MIF activity in thymic cell culture supernatants seemed to be antigen-independent, although in this respect no definitive conclusions can be drawn from the present results. Migration inhibition in direct and indirect techniques always correlated with a positive delayed-type skin reaction. It is suggested that a population of thymus cells of sensitized animals is able to produce MIF on specific antigenic stimulation in vitro. This might support the idea that a cell population within the thymus possesses characteristics of peripheral T cells.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1099009

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  2 in total

1.  Migration inhibition of lymph node lymphocytes as an in vitro assay for cell-mediated immunity in the draining lymph nodes of parenterally immunized mice.

Authors:  A M Mowat; A Ferguson
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

2.  Immunoregulation and anti-nuclear antibodies in mercury-induced glomerulopathy in the rat.

Authors:  J J Weening; P J Hoedemaeker; W W Bakker
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.